Nuveen Asset Management, LLC Bio Rad Laboratories, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 59,409 shares of BIO stock, worth $19.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,409

Previous 91,477 35.06%

Holding current value

$19.7 Million

Previous $31.6 Million 48.72%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$268.26 - $339.48 $8.6 Million - $10.9 Million	-32,068 Reduced 35.06%	59,409 $16.2 Million
Q1 2024 May 13, 2024	BUY	$304.11 - $351.99 $986,836 - $1.14 Million	3,245 Added 3.68%	91,477 $31.6 Million
Q4 2023 Feb 14, 2024	SELL	$269.37 - $365.04 $801,375 - $1.09 Million	-2,975 Reduced 3.26%	88,232 $28.5 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $4.1 Million - $4.95 Million	-11,707 Reduced 11.38%	91,207 $32.7 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $1.28 Million - $1.73 Million	3,560 Added 3.58%	102,914 $39 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $21.2 Million - $25.5 Million	50,661 Added 104.04%	99,354 $47.6 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $10.9 Million - $14.1 Million	-31,010 Reduced 38.91%	48,693 $20.5 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $599,493 - $818,416	-1,453 Reduced 1.79%	79,703 $33.2 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $255,018 - $328,438	550 Added 0.68%	81,156 $40.2 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $5.04 Million - $7.06 Million	9,599 Added 13.52%	80,606 $46.8 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $8.25 Million - $9.25 Million	11,645 Added 19.62%	71,007 $53.7 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $1.66 Million - $2.08 Million	-2,519 Reduced 4.07%	59,362 $44.3 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $20.4 Million - $23 Million	-35,385 Reduced 36.38%	61,881 $39.9 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $9.89 Million - $12 Million	18,073 Added 22.82%	97,266 $55.6 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $11.4 Million - $14.3 Million	22,265 Added 39.11%	79,193 $46.2 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $1.12 Million - $1.32 Million	2,470 Added 4.54%	56,928 $29.3 Million
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $3.44 Million - $5.07 Million	-10,282 Reduced 15.88%	54,458 $24.6 Million
Q1 2020 May 14, 2020	SELL	$320.01 - $409.07 $2.15 Million - $2.75 Million	-6,734 Reduced 9.42%	64,740 $22.7 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $6.66 Million - $7.8 Million	-20,838 Reduced 22.57%	71,474 $26.4 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $3.07 Million - $3.48 Million	10,076 Added 12.25%	92,312 $30.7 Million
Q2 2019 Aug 15, 2019	BUY	$286.93 - $312.59 $23.6 Million - $25.7 Million	82,236 New	82,236 $25.7 Million

Others Institutions Holding BIO

# of Institutions

461

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.18B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Bio Rad Laboratories, Inc. Transaction History